Seema Sinha, PhD, MBA, is passionate about commercializing innovations for patient care. They have served as a Licensing Analyst and Licensing Officer at Vanderbilt University and held research and strategy roles at institutions like Fred Hutch and Labcorp. Currently, Seema directs diagnostic strategy at Labcorp and technology strategy at Nucleate Seattle, while pursuing advanced degrees in Cancer Biology and Business Administration. Previously, they completed a Ph.D. in Cancer Biology at Vanderbilt University Medical Center and a Master of Science in Biological Sciences at the University at Buffalo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices